Login to Your Account

Innovative drugmakers challenged to increase affordability

China’s leadership renews commitment to cut drug prices; biologics largely immune

By Shannon Ellis
Staff Writer

Wednesday, December 11, 2013

SHANGHAI – After a flurry of high-level meetings discussing China’s drug pricing, the new leadership said it will continue to apply pressure on drug prices to reduce the cost of healthcare, but will make greater use of market forces.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription